Pharmaceutical Development

IQ Consortium Enabling Technologies for Pharma

Conference Presentation
AIChE Annual Meeting
November 9, 2015
The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) is a technically-focused organization of pharmaceutical...

Quality by Design in Pharmaceutical Development

Conference Presentation
AIChE Annual Meeting
November 7, 2010
More than 70% of the prescriptions in the US are now filled with generic products, and therefore, the industry has the responsibility to continue to...

A Materials Approach to Vaccines as Therapies

October
2017
SBE Special Section
Neil Dold, Christopher M. Jewell
The widespread adoption of vaccines over the last two centuries has transformed medicine by preventing infectious disease. In the future, so-called therapeutic vaccines could be used as effective treatments for cancer and autoimmune disorders — ushering in a new era of medicine.

Engineering Cancer-Fighting T Cells

October
2017
SBE Special Section
Eugenia Zah, Yvonne Y. Chen
Adoptive T-cell therapy is a personalized cancer treatment that has the potential to cure previously untreatable malignancies. Researchers are applying techniques in biomolecular engineering and synthetic biology to the development of next-generation therapeutic T cells with improved safety and efficacy against a variety of cancers.

Little Bio-Machinery to Solve Grand Challenges

January 3, 2017
As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.

Study Points to Therapeutic Cancer Vaccine

December 30, 2016

Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.

Medical Potential for Temporary Nanoparticle Tattoos

September 26, 2016

Tests by researchers at Baylor College of Medicine have recently shown that nanoparticles modified with polyethylene glycol selectively affect specific areas of the immune system, showing potential

Subscribe to Pharmaceutical Development